BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Talks.cam//talks.cam.ac.uk//
X-WR-CALNAME:Talks.cam
BEGIN:VEVENT
SUMMARY:3rd Biological and Medicinal Chemistry Symposium for Postgraduates
  -  Dr Tony Wood (Worldwide Head of Medicinal Chemistry\, Pfizer)\;  P
 rof Malcolm Stevens (University of Nottingham)\; Prof Shankar Balasubraman
 ian (University of Cambridge).
DTSTART:20091211T090000Z
DTEND:20091211T180000Z
UID:TALK20135@talks.cam.ac.uk
CONTACT:Dr Rebecca Myers
DESCRIPTION:ALL WELCOME\n\nIt’s free to attend but you must register bef
 ore 1 December 2009. Send completed registration form by email to Dr Rebec
 ca Myers with “REGISTRATION BMCS SYMPOSIUM” in the subject line. There
  are 3 specially invited speakers plus 9 selected students talks plus a po
 ster session.\n\nSESSION 1   (CHAIR) DR GORDON SAXTY\, ASTEX THERAPEUTICS 
 LTD\n  \nWelcome Prof Steven Ley University of Cambridge    \n\nQuadrupl
 ex Nucleic Acids as Functional Elements and Therapeutic Targets\, Prof Sha
 nkar Balasubramanian University of Cambridge    \n\nSynthesis of Aminodi
 ols: The Use of Transketolase and Transaminase for Stereoselective Organic
  Synthesis\, Armando Cazares University College London   \n\nInvestigation
  of the Effect of Small Molecules on Chromatin Modification\, Annabelle Ni
 colas University of Cambridge   \n\nDevelopment of 6-Substituted Purines a
 s Selective Inhibitors of Cyclin-Dependent Kinase 2 (CDK2)\, Christopher C
 oxon Newcastle University   \n\nSESSION 2  (CHAIR) DR DOUGLAS WILLIAMSON\,
  VERNALIS LIMITED\n \nChemical Whispering and the Search for Novel Antitum
 our Drugs\nProf Malcolm Stevens School of Pharmacy\, University of Notting
 ham   \n\nTowards Selective Anti-tuberculosis Agents\, Bilal Aljaidi Strat
 hclyde institute of Pharmacy and Biomedical Sciences   \n\nSwitchable Biol
 ogical Surfaces\, Chun Ling Yeung School of Chemistry\, University of Birm
 ingham   \n\nProbing the ATP-Binding Domain of DNA-Dependent Protein Kinas
 e (DNA-PK) with coumarin- and isocoumarin-Derived Inhibitors\, Sara Payne 
 School of Chemistry\, Newcastle University   \n\n\nSESSION 3  (CHAIR) DR D
 AVE ALKER\, DAVE ALKER ASSOCIATES\n\nChemical Biology Challenges for 21st 
 Century Medicinal Chemistry\nDr Tony Wood VP and Head of Worldwide Medicin
 al Chemistry\, Pfizer Global R&D  \n\nPeptide Components for Synthetic Bio
 logy\, Craig Armstrong University of Bristol   \n\nActivity-Based Probes R
 eveal a Putative S-Layer Processing Complex in C. difficile\, Tam Dang Imp
 erial College London   \n\nTowards Candidate Selection of a Novel 1\,2\,4\
 ,5-Tetraoxane with Antimalarial Properties Superior to the Semi-Synthetic 
 Artemisinin\nDr Richard Amewu University of Liverpool   \n\nClosing Remark
 s Dr Dave Alker   \n\nFollowed by a wine mixer and presentation of prizes 
 by Dr Tony Wood. \n\nThe symposium is generously sponsored by Eisai\, BioF
 ocus\, Vernalis\, Heptares\, RSC Mid-Anglia\, GSK\, Astex\, Takeda\, Astra
 zeneca and Pfizer.\n\nRSC BMCS PG Symposium Organising Committee: Dr Rebec
 ca Myers\, Dr Dave Alker\, Dr Gordon Saxty (Astex)\n\nRegistration forms a
 re available from here: "http://www-medchem.ch.cam.ac.uk/symposium08.php"
LOCATION:Wolfson Lecture Theatre\, Department of Chemistry\, Lensfield Roa
 d\, University of Cambridge\, CB2 1EW
END:VEVENT
END:VCALENDAR
